mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
21st March 2025
Tiago Azenha Rama, André Moreira, Mariana Castells (2021). This article is a case report of two individuals with cutaneous and systemic mastocytosis who underwent the COVID-19 vaccination with premedication and did not experience side effects. This article reinforce how understanding mastocytosis and taking the appropriate step can allow safe vaccination practice.
Become a friend
Sign up to become a Friend of Mast Cell Action so we can keep you up to date on our progress and on how to get involved in our latest campaigns and initiatives.
Donate
Mast Cell Action relies entirely on the generosity of people like you. Please make a donation now and together we can make a difference to those affected by MCAS.
